UKB NewsRoom | Auszeichnung für herausragende Krebsforscher + + + mehr:
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
S. Heine, Ann-Kristin Hedmark & Gunnar Bergsten | Play on Anghami
Krebszentrum CIO Bonn - Posts | Facebook
UKB NewsRoom | Annkristin Heine
Krebszentrum CIO Bonn - Posts | Facebook
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
ImmunoSensation / The Immune Sensory System » Members
PDF) The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
AG Heine - Hämatologie und Onkologie der Universitätsklinikum Bonn
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
Loop | Annkristin Heine
Erfolg bei Ausschreibung? Advanced Clinician Scientist? - Forschende Mediziner erhalten Förderung durch das BMBF - MINQ Magazin
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
Prof. Dr. Annkristin Heine — Medizinische Fakultät der UBonn
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
Annkristin HEINE | senior physician | Dr. med. | University of Bonn - Medical Center, Bonn | Haematology Oncology
Volume 13, Issue 2, Pages (February 2006) - ppt download
